For its fourth fiscal quarter (ending December 31), Wendy’s Co (NASDAQ: WEN) has reported a 0% change in E.P.S. from $0.23 a year ago to $0.23 in the current quarter. Relative to the consensus estimate […]
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has reported E.P.S. of $-0.08 for its fourth fiscal quarter (ending December 31) versus $-0.04 for the same period a year ago. E.P.S. were $-0.33 for the latest four quarters […]
For its second fiscal quarter (ending January 31), Palo Alto Networks Inc (NASDAQ: PANW) has reported a -93% decline in E.P.S. from $5.47 a year ago to $0.41 in the current quarter. This result fell […]
For its fourth fiscal quarter (ending December 31), Nu Skin Enterprises Inc. (NYSE: NUS) has reported a -587% decline in E.P.S. from $0.15 a year ago to $-0.73 in the current quarter. This performance was […]
Nova Ltd (NASDAQ: NVMI) has reported E.P.S. of $1.72 for its fourth fiscal quarter (ending December 31) versus $1.31 for the same period a year ago — an increase of 31%. However, this performance was […]
For its fourth fiscal quarter (ending December 31), Hanesbrands Inc (NYSE: HBI) has reported a -41% decline in E.P.S. from $0.22 a year ago to $0.13 in the current quarter. This result fell short of […]
For its fourth fiscal quarter (ending December 31), DaVita Inc (NYSE: DVA) has reported a 90% increase in E.P.S. from $1.67 a year ago to $3.18 in the current quarter. This performance was $1.03 better […]
For its fourth fiscal quarter (ending December 31), DTE Energy Co (NYSE: DTE) has reported a -30% decline in E.P.S. from $2.02 a year ago to $1.41 in the current quarter. This performance was $-0.03 […]
For its fourth fiscal quarter (ending December 31), ALLETE Inc. (NYSE: ALE) has reported a -1% decline in E.P.S. from $0.89 a year ago to $0.88 in the current quarter. This performance was $-0.20 short […]
Zoetis Inc (NYSE: ZTS) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.29 versus $1.14 for the same period a year ago — an increase of 13%. However, this performance was […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research